Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4
- PMID: 8474162
- PMCID: PMC237577
- DOI: 10.1128/JVI.67.5.2566-2574.1993
Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4
Abstract
Human immunodeficiency virus type 1 (HIV-1) infects human CD4+ cells by a high-affinity interaction between its envelope glycoprotein gp120 and the CD4 molecule on the cell surface. Subsequent virus entry into the cells involves other steps, one of which could be cleavage of the gp120 followed by virus-cell fusion. The envelope gp120 is highly variable among different HIV-1 isolates, but conserved amino acid sequence motifs that contain potential proteolytic cleavage sites can be found. Following incubation with a soluble form of CD4, we demonstrate that gp120 of highly purified HIV-1 preparations is, without addition of exogenous proteinase, cleaved most likely in the V3 loop, yielding two proteins of 50 and 70 kDa. The extent of gp120 proteolysis is HIV-1 strain dependent and correlates with the recombinant soluble CD4 sensitivity to neutralization of the particular strain. The origin of the proteolytic activity in the virus preparations remains unclear. The results support the hypothesis that cleavage of gp120 is required for HIV infection of cells.
Similar articles
-
T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.Eur J Biochem. 1996 Apr 1;237(1):64-70. doi: 10.1111/j.1432-1033.1996.0064n.x. Eur J Biochem. 1996. PMID: 8620895
-
Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.J Virol. 1999 May;73(5):4360-71. doi: 10.1128/JVI.73.5.4360-4371.1999. J Virol. 1999. PMID: 10196334 Free PMC article.
-
Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.Adv Enzyme Regul. 1996;36:325-47. doi: 10.1016/0065-2571(95)00016-x. Adv Enzyme Regul. 1996. PMID: 8869754
-
Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.J Virol. 1997 Nov;71(11):8289-98. doi: 10.1128/JVI.71.11.8289-8298.1997. J Virol. 1997. PMID: 9343181 Free PMC article.
-
Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article.
Cited by
-
An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades.J Virol. 1998 Oct;72(10):7840-5. doi: 10.1128/JVI.72.10.7840-7845.1998. J Virol. 1998. PMID: 9733820 Free PMC article.
-
Exposure of p19 matrix protein of human T-cell leukemia virus type I (HTLV-I) on the surface of MOLT-4#8 cells after virus adsorption.Arch Virol. 1994;136(3-4):389-95. doi: 10.1007/BF01321067. Arch Virol. 1994. PMID: 8031242 Free PMC article.
-
A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.J Virol. 1996 Jul;70(7):4451-6. doi: 10.1128/JVI.70.7.4451-4456.1996. J Virol. 1996. PMID: 8676469 Free PMC article.
-
Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry.Biochemistry. 2010 Oct 26;49(42):9032-45. doi: 10.1021/bi1011332. Biochemistry. 2010. PMID: 20825246 Free PMC article.
-
Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker.J Virol. 2006 Jul;80(14):6725-37. doi: 10.1128/JVI.00118-06. J Virol. 2006. PMID: 16809278 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials